Mir Ali, MD, is a bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center
This finding underscores the critical importance of baseline ophthalmologic assessment and ongoing monitoring for patients with established retinopathy, particularly when initiating potent glucose-lowering therapies that can cause large and swift reductions in HbA1c
FDA approves Ozempic (semaglutide) for type 2 diabetes. December 5, 2017
For 95% of people: don't wait
DT Peptides is committed to being a thought leader in emerging obesity treatments, and were excited for what the future holds.)
Evaluating Zealthy Legit Against Evidence-Based GLP-1 Care Standards To assess Zealthy Legit's credibility, ask whether prescribers are board-certified in family medicine, internal medicine, or endocrinology